Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Biopharma
54 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
CDMO - Small Biotech
Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility
PAO-02-24-CL-07
Tech Transfer
Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies
PAO-02-24-CL-06
Synthetic DNA
Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?
PAO-01-24-NI-04
Retinal Disease
Pioneering Breakthroughs in Retinal Disease Treatment
PAO-12-23-CL-01
Supply Chain
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
PTV-12-23-CL-02
CDMO Selection
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
PAO-11-23-CL-04
CMC
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
PAO-07-23-CL-05
Critical Cleaning
Aqueous Critical Cleaning for Pharma and Biopharma Applications (Companion to Aqueous Cleaning Handbook)
PAO-04-23-CL-03
UN Global Compact
CDMO Joins United Nations Global Compact
PR-M03-23-02
Contamination Control Event
Ecolab and Pharma’s Almanac Present Contamination Control Event
PAO-11-022-CL-04
Miniaturized Mass Spectrometry
Bringing Mass Spectrometry out of the Lab and to the Point of Need
PAO-09-022-CL-10
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
PR-M09-22-01
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
PAO-08-022-CL-01
Decontamination Solutions
A Guide on Comprehensive Decontamination Solutions for the Pharmaceutical Industry
PAO-08-022-CL-08
New Project Funding
NIIMBL Announces $15.8M to Fund 14 New Biopharmaceutical Manufacturing Projects
PR-M08-22-02
Contamination Control
Contamination Control Strategies for the Manufacture of Conventional and Next-Generation Biologics
PAO-07-022-CL-07
New Biodefense Facility
Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility
PR-M04-22-12
Data Mapping
Adding Dimensionality to Data Mapping for Higher-Level Analysis
PAO-04-022-CL-03
Strategic Alliance
Rentschler Biopharma and Vetter Unveil Xpert Alliance
PR-M03-22-14
Automation
Advancing the Science of What's Possible
PAO-02-22-R250-13
Growing Industry
Expanding the Bioscience Industry in Montana
PAO-02-22-R250-05
Process Development
Shortening Biopharmaceutical Process Development Timelines with High-Throughput Approaches.
PAO-11-21-CL-02
Social Media Marketing
Q: What’s the next “big thing” on the horizon that will significantly alter the pharma/biopharma market, your operations, or the way you do business?
Biopharma
Assessing the Dynamic Market for Biologics
PAO-04-22-R221-23
1
3
»